Core Viewpoint - Jin Hai Medical Technology (02225) experienced a significant decline in stock price, dropping over 36% during trading, with an intraday drop exceeding 65% [1] Group 1: Stock Performance - As of the report, the stock price of Jin Hai Medical Technology was down 36.11%, trading at 1.15 HKD, with a trading volume of 161 million HKD [1] - The company announced a subscription agreement with three independent private investors to issue a total of 120 million shares at a subscription price of 1.35 HKD per share [1] Group 2: Subscription Details - The subscription price of 1.35 HKD represents a discount of approximately 17.68% compared to the closing price of 1.64 HKD on the date of the subscription agreement [1] - The net proceeds from the subscription, after deducting all applicable costs and expenses, are expected to be around 160 million HKD, with a net issuance price of approximately 1.34 HKD per share [1] Group 3: Use of Proceeds - The company plans to use the proceeds from the subscription for potential acquisitions in the healthcare sector, funding for healthcare-related projects, research and development expenses, and general working capital [1]
港股异动 | 今海医疗科技(02225)盘中跌超36% 公司近期拟折让约17.68%发行合共1.2亿股认购股份